Ladurot (Tamsulosin Hydrochloride, Dutasteride)

Tamsulosin blocks α1A‑adrenergic receptors in the prostate and bladder neck, reducing dynamic muscle tone and easing urine passage. Dutasteride inhibits both type I and type II 5‑alpha‑reductase enzymes, lowering dihydrotestosterone production, which slows prostate growth and can shrink gland size over time.

The prescribed dose of Ladurot is determined by the treating physician based on the patient’s clinical condition, renal and hepatic function, and concomitant medications. Healthcare professionals follow local prescribing guidelines and adjust therapy as needed; patients should follow the prescriber’s instructions exactly.

Ladurot is not indicated for use in pregnant or breastfeeding women. Safety data are limited, and the drug class may affect hormonal pathways. It is generally avoided in these populations, and alternative treatments should be considered under medical supervision.

To order Ladurot, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ladurot combines an α‑blocker (tamsulosin) with a 5‑alpha‑reductase inhibitor (dutasteride), offering both rapid symptom relief and long‑term prostate size reduction. Compared with monotherapy, the combination can provide faster improvement in urinary flow while also decreasing the risk of disease progression, though it may carry a broader side‑effect profile.

Ladurot tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect the product from excess moisture, direct sunlight and heat. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Ladurot is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

Serious risks include intraoperative floppy iris syndrome, which can complicate cataract surgery, severe hypotension leading to fainting, and rare allergic reactions such as anaphylaxis. Patients should report sudden vision changes, severe dizziness, swelling, rash or difficulty breathing to their clinician promptly.

Ladurot should be avoided in individuals with known hypersensitivity to tamsulosin, dutasteride, or any tablet excipients. Caution is advised for patients with severe liver disease, uncontrolled low blood pressure, or a history of prostate cancer where hormonal manipulation is contraindicated. Consultation with a physician is essential before starting therapy.